Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
5.93
-0.34 (-5.42%)
At close: Aug 1, 2025, 4:00 PM
5.98
+0.05 (0.84%)
After-hours: Aug 1, 2025, 6:03 PM EDT
Silk Road Medical Market Cap
Liminatus Pharma has a market cap or net worth of $153.75 million as of August 1, 2025. Its market cap has increased by 80.96% in one year.
Market Cap
153.75M
Enterprise Value
183.03M
1-Year Change
80.96%
Ranking
Category
Stock Price
$5.93
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $153.75M, a decrease of -55.57%. That is a compound annual growth rate of -17.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 163.11M | 103.64% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |